CN111925317B - 一种盐酸罗哌卡因杂质及其制备方法 - Google Patents
一种盐酸罗哌卡因杂质及其制备方法 Download PDFInfo
- Publication number
- CN111925317B CN111925317B CN202010810082.1A CN202010810082A CN111925317B CN 111925317 B CN111925317 B CN 111925317B CN 202010810082 A CN202010810082 A CN 202010810082A CN 111925317 B CN111925317 B CN 111925317B
- Authority
- CN
- China
- Prior art keywords
- ropivacaine hydrochloride
- formula
- vilsmeier
- haack
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 title claims abstract description 72
- 229960001813 ropivacaine hydrochloride Drugs 0.000 title claims abstract description 72
- 239000012535 impurity Substances 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 33
- 238000006243 chemical reaction Methods 0.000 claims abstract description 32
- 150000001875 compounds Chemical class 0.000 claims abstract description 17
- ZMXDDKWLCZADIW-UHFFFAOYSA-N Vilsmeier-Haack reagent Natural products CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 42
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- 238000005874 Vilsmeier-Haack formylation reaction Methods 0.000 claims description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 238000010791 quenching Methods 0.000 claims description 8
- 230000000171 quenching effect Effects 0.000 claims description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 150000001266 acyl halides Chemical class 0.000 claims description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical group ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 238000001953 recrystallisation Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 3
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 claims description 2
- 239000012346 acetyl chloride Substances 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 claims description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 8
- 238000003908 quality control method Methods 0.000 abstract description 8
- 238000003786 synthesis reaction Methods 0.000 abstract description 8
- 230000003444 anaesthetic effect Effects 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 6
- 238000004458 analytical method Methods 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 238000007086 side reaction Methods 0.000 abstract description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 238000000605 extraction Methods 0.000 description 9
- 229960001701 chloroform Drugs 0.000 description 5
- SILRCGDPZGQJOQ-UHFFFAOYSA-N 2,6-Pipecoloxylidide Chemical compound CC1=CC=CC(C)=C1NC(=O)C1NCCCC1 SILRCGDPZGQJOQ-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- 229940052294 amide local anesthetics Drugs 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N deuterated chloroform Substances [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000002692 epidural anesthesia Methods 0.000 description 1
- NGAZZOYFWWSOGK-UHFFFAOYSA-N heptan-3-one Chemical compound CCCCC(=O)CC NGAZZOYFWWSOGK-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Abstract
Description
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010810082.1A CN111925317B (zh) | 2020-08-12 | 2020-08-12 | 一种盐酸罗哌卡因杂质及其制备方法 |
PCT/CN2020/133210 WO2022032936A1 (zh) | 2020-08-12 | 2020-12-02 | 一种盐酸罗哌卡因杂质及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010810082.1A CN111925317B (zh) | 2020-08-12 | 2020-08-12 | 一种盐酸罗哌卡因杂质及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111925317A CN111925317A (zh) | 2020-11-13 |
CN111925317B true CN111925317B (zh) | 2022-04-08 |
Family
ID=73310907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010810082.1A Active CN111925317B (zh) | 2020-08-12 | 2020-08-12 | 一种盐酸罗哌卡因杂质及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN111925317B (zh) |
WO (1) | WO2022032936A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111925317B (zh) * | 2020-08-12 | 2022-04-08 | 广东嘉博制药有限公司 | 一种盐酸罗哌卡因杂质及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109053623A (zh) * | 2018-08-27 | 2018-12-21 | 济南悟通生物科技有限公司 | 一种4-甲基-5-噻唑甲醛的新型制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111925317B (zh) * | 2020-08-12 | 2022-04-08 | 广东嘉博制药有限公司 | 一种盐酸罗哌卡因杂质及其制备方法 |
-
2020
- 2020-08-12 CN CN202010810082.1A patent/CN111925317B/zh active Active
- 2020-12-02 WO PCT/CN2020/133210 patent/WO2022032936A1/zh active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109053623A (zh) * | 2018-08-27 | 2018-12-21 | 济南悟通生物科技有限公司 | 一种4-甲基-5-噻唑甲醛的新型制备方法 |
Non-Patent Citations (2)
Title |
---|
LIU Ming等.Pharmacophore screening on piperidinecarboxamides derivatives based on GALAHAD and CoMFA models.《Chinese Journal of Chemistry》.2011,第1075-1083页. * |
Pharmacophore screening on piperidinecarboxamides derivatives based on GALAHAD and CoMFA models;LIU Ming等;《Chinese Journal of Chemistry》;20110630;第1075-1083页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111925317A (zh) | 2020-11-13 |
WO2022032936A1 (zh) | 2022-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108558692B (zh) | 一种酰胺类化合物的制备方法 | |
CN111925317B (zh) | 一种盐酸罗哌卡因杂质及其制备方法 | |
CN110551023A (zh) | 一种制备烷基二酸单苄酯的方法 | |
CN113416150B (zh) | 一种洛铂中间体的合成方法 | |
CN101812014A (zh) | 一种苯磺酸氨氯地平化合物及其新制法 | |
CN107311960A (zh) | 1,2,3‑苯并噻二唑类化合物的合成方法 | |
CN106397516A (zh) | 坎格雷洛中间体及其制备方法和应用 | |
CN105254515A (zh) | 一种氯化琥珀胆碱的制备方法 | |
CN115124466A (zh) | 一种四氢罂粟碱盐酸盐的合成方法 | |
CN111100042B (zh) | 一种2-甲氧基-5-磺酰胺基苯甲酸的制备方法 | |
EP3896057B1 (en) | Method for continuously preparing citalopram diol | |
CN111925303A (zh) | 一种盐酸罗哌卡因杂质的制备方法 | |
CN108558974B (zh) | 一种糖衍生吡啶三氮唑镍催化剂的制备及应用 | |
CN108409615B (zh) | 一种合成对映纯叔丁基亚磺酰胺的方法 | |
CN107573279B (zh) | 一种苯磺酸氨氯地平降解杂质的合成方法 | |
CN109574938B (zh) | 一种瑞舒伐他汀钠的合成方法 | |
CN112110879A (zh) | 一种舒欣啶游离碱的制备方法 | |
CN111747926A (zh) | 一种羟哌吡酮游离碱的合成工艺改进方法 | |
CN113354573B (zh) | 一种可规模化生产α,α,α-三联吡啶的方法 | |
CN112939892B (zh) | 一种喹硫平的制备方法 | |
CN114990590B (zh) | 一种电催化无金属转酰胺化反应的新方法 | |
CN116253659B (zh) | 一种酰胺基烯胺类化合物及其制备方法与应用 | |
CN108822060B (zh) | 一种3-芳基取代氧杂环丁烷及其制备方法 | |
CN111333528B (zh) | 一种多构型o-苯基-丝氨酸类化合物的合成方法 | |
CN110684989B (zh) | 一种电化学合成6-叠氮甲基菲啶类化合物的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A kind of ropivacaine hydrochloride impurity and preparation method thereof Effective date of registration: 20220829 Granted publication date: 20220408 Pledgee: Industrial and Commercial Bank of China Co.,Ltd. Qingyuan Economic Development Zone Sub branch Pledgor: GUANGDONG JIABO PHARMACEUTICAL Co.,Ltd. Registration number: Y2022980013893 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20220408 Pledgee: Industrial and Commercial Bank of China Co.,Ltd. Qingyuan Economic Development Zone Sub branch Pledgor: GUANGDONG JIABO PHARMACEUTICAL Co.,Ltd. Registration number: Y2022980013893 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |